The Randomized Linxian Dysplasia Nutrition Intervention Trial after 26 Years of Follow-Up: No Effect of Multivitamin Supplementation on Mortality

Jian-Bing Wang,Christian C. Abnet,Jin-Hu Fan,You-Lin Qiao,Philip R. Taylor
DOI: https://doi.org/10.1001/jamainternmed.2013.6066
2013-01-01
JAMA Internal Medicine
Abstract:Correspondence to: You-Lin Qiao, Department of Cancer Epidemiology, Cancer Hospital/Institute, Chinese Academy of Medical Sciences, 17 South Panjiayuan Lane, Beijing 100021, PR China (nc.ca.smacic@yoaiq); and Philip R Taylor, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rm 7006, Rockville, Maryland, 20852-7236, USA (vog.hin.liam@rolyatp) Although substantial numbers of people worldwide take multivitamin supplements, including an estimated 40% or more of US adults, their effectiveness remains unclear. Recent reports from the Physicians’ Health Study (PHS) II, a randomized trial of daily multivitamins, found fewer total cancers in multivitamin recipients, but no effect on overall or cause-specific mortality 1, 2 in a Western population that was well nourished. However, few multivitamin trials have been conducted in under-nourished populations where the potential for benefit is most likely. In 1985, we initiated the Linxian Dysplasia Nutrition Intervention Trial (NIT) to evaluate the effect of multivitamin supplements on cancer incidence and mortality in Linxian, China, a region with extremely high rates of esophageal and gastric cardia cancer and multiple vitamin and mineral deficiencies. Individuals with a previous cytological diagnosis of esophageal squamous dysplasia were randomized to receive multivitamin supplementation or placebo for six years.3 Results after the six-year intervention period showed no statistically significant benefit on mortality.4 However, an additional 20 years of active follow-up after cessation of the intervention gave us the opportunity to examine the long-term effects of supplementation. The purpose of this report is to update results of the Linxian Dysplasia NIT after 26 years of follow-up to provide data informative on the effect of multivitamin supplementation on mortality in an under-nourished population. Our findings should be helpful for clinical practice and public health recommendations.
What problem does this paper attempt to address?